Skip to content
Search

Latest Stories

Doctors warn of new covid symptom as nimbus variant spreads across the UK

Doctors have identified a distinctive new symptom: A razor blade sore throat

What Makes the 'Nimbus' Covid Variant Symptoms Different?

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants

iStock

A new covid variant, known as nimbus (scientifically NB.1.8.1), is causing concern among health experts as cases rise globally. The variant, a descendant of omicron, has been detected in several countries, including China, Singapore, Hong Kong, and the UK. While its symptoms are largely similar to previous covid strains, doctors have identified a distinctive new symptom: a razor blade sore throat, characterised by an intense stabbing pain when swallowing.

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants, which could lead to increased transmission rates. Although there is no current evidence to suggest that it causes more severe illness than its predecessors, the rapid spread has raised concerns, particularly among vulnerable groups.


Symptoms of nimbus

Like previous Covid variants, nimbus presents with a range of symptoms, including fever, muscle aches, congestion, and shortness of breath. However, one symptom, in particular, is capturing attention—the razor blade sore throat. This sensation, described by medical experts as a sharp, stabbing pain at the back of the throat, makes swallowing extremely uncomfortable.

Other symptoms include redness in the throat, swollen neck glands, and general discomfort when eating or drinking. Some patients have also reported experiencing fatigue, headaches, and a persistent cough. While these symptoms may overlap with those of earlier variants, doctors emphasise that the severity and persistence of the sore throat are unique to nimbus.

Spread and concerns

Although only a small number of cases have officially been recorded in the UK, experts believe the actual spread of nimbus could be significantly wider. This is due to the decline in routine Covid testing since the height of the pandemic. According to UK Health Security Agency (UKHSA) data, the number of people testing positive for Covid has increased significantly in recent months. Reports indicate that infection rates have surged by 97% compared to figures recorded earlier in the year.

Virologists are warning that the number of Covid cases could continue to rise, particularly as summer approaches. Increased social interaction, crowded events, and holiday travel all create conditions for virus transmission. Professor Lawrence Young, a virologist at Warwick University, notes that while many respiratory viruses, such as flu, tend to subside in warmer climates, Covid continues to spread even in hot and humid weather. This makes it difficult to predict the scale of a possible summer wave.

Another concerning aspect is that population immunity, whether from vaccination or prior infection, appears to be waning over time. This means that even those who have had previous covid infections or vaccinations may still be at risk of catching nimbus.

Severity and vaccination

Laboratory studies suggest that nimbus is capable of infecting human cells more efficiently than previous strains. While there is no evidence indicating that it leads to more severe illness or higher fatality rates than earlier Covid variants, doctors stress that infection can still be dangerous for vulnerable individuals.

In May alone, Covid was a contributing factor in the deaths of over 300 people in England. The elderly, individuals with weakened immune systems, and those with pre-existing medical conditions remain particularly at risk.

What Makes the 'Nimbus' Covid Variant Symptoms Different?The UKHSA is closely monitoring its progression and is assessing its impact on public healthiStock

Vaccination continues to be the strongest defence against severe illness. Experts say that current Covid vaccines, reformulated to target omicron-related variants, are expected to offer protection against nimbus. Research indicates that individuals who received a Covid booster jab as part of last spring’s vaccination campaign were 45% less likely to require hospital care following infection, compared to those who had not been vaccinated.

Global outlook

According to the World Health Organisation (WHO), nimbus now accounts for 10.7% of global Covid cases, a sharp increase from just 2.5% a month earlier. The UKHSA is closely monitoring its progression and is assessing its impact on public health.

Dr Gayatri Amirthalingam, deputy director of the UKHSA, has stated that the organisation is keeping track of all available data related to Covid variants in the UK and abroad. While nimbus has only been detected in small numbers in the UK so far, international data indicates that it is growing as a proportion of all Covid cases worldwide.

Preventative measures and vaccination eligibility

Health authorities continue to urge eligible individuals to receive their Covid vaccinations. In the UK, free vaccines are available for specific groups, including people aged 75 and older, care home residents, and those with weakened immune systems. This includes patients undergoing cancer treatment, organ transplant recipients, and individuals with genetic disorders that affect the immune system.

Getting vaccinated remains essential in protecting against severe illness and hospitalisation. While nimbus may not be more lethal than previous variants, experts emphasise that its ability to infect cells efficiently makes it highly transmissible. Vigilance, personal hygiene, and vaccination all play crucial roles in reducing the risk of infection.

The spread

The emergence of the nimbus variant is a stark reminder that Covid continues to evolve. While symptoms are similar to previous strains, the distinct razor blade sore throat is emerging as a defining characteristic of the latest variant. Experts warn that its ability to spread efficiently could lead to a summer surge in cases, particularly as population immunity declines.

Although there is no evidence that nimbus causes more severe illness than past variants, it remains a threat to vulnerable individuals. Health officials continue to recommend vaccination as the best means of protection. With the UKHSA closely monitoring its spread, staying informed and maintaining caution remain essential as the situation develops.

More For You

Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Hulk Hogan

Hogan’s current hospital stay follows a neck fusion surgery he underwent in May 2025

Getty Images

Hulk Hogan hospitalised for back and neck issues, rep confirms he is not on deathbed

WWE Hall of Famer Hulk Hogan has been hospitalised for ongoing neck and back issues, but representatives have confirmed he is not in critical condition, dismissing online speculation suggesting otherwise.

The 71-year-old wrestling icon, whose real name is Terry Bollea, was reported by TMZ Sports to be undergoing treatment related to injuries sustained during his decades-long in-ring career. His representative said Hogan is already mobile again and “not on his deathbed”, following false claims made on air by Florida radio personality Bubba the Love Sponge.

Keep ReadingShow less
UK heatwave health risks

Several hidden threats linked to heat waves often go unnoticed

iStock

7 hidden heatwave health risks you may overlook

As temperatures across the UK continue to rise, so too do the health risks associated with extreme heat. While sunburn and dehydration are well-known dangers, several hidden threats linked to heat waves often go unnoticed. With climate change intensifying the frequency and severity of hot spells, some forecasts suggesting 40 °C days could become a regular feature in the next 12 years, it’s essential to understand these lesser-known risks and how to protect yourself.

1. Skin reactions triggered by common medications

Certain widely-used medications can increase sensitivity to sunlight, making people more prone to rashes, blistering, and sunburn—even on cloudy days. This includes nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, some antibiotics such as doxycycline, statins, antidepressants, and hormone replacement therapy (HRT).

Keep ReadingShow less